T2 Biosystems (TTOO) said Tuesday the Nasdaq Hearings Panel has determined to delist its shares, with trading of the stock to be suspended from Feb. 12.
The company said it does not plan to pursue any further appeal of the ruling after it failed to meet the requirements for bid price and the market value of listed securities.
T2 said its shares are expected to begin trading on the OTC Markets system Wednesday.
Shares of T2 Biosystems were down about 20% in recent trading.
Price: 0.15, Change: -0.04, Percent Change: -20.68
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。